Between 2018 and 2022, spending increased nearly 19%, average out-of-pocket spending exceeded $860 among people who get insurance through work
WASHINGTON, April 25, 2024 /PRNewswire/ — A new report from the Health Care Cost Institute (HCCI) shows that, even with fluctuations in 2020 and 2021, per person health care spending grew from 2018 to 2022. Over the five years, average prices increased by 14% and utilization went up by about 4%. Data in HCCI’s annual Health Care Cost and Utilization Report (HCCUR) illustrate that, although utilization of services went up and down over the course of the five years, average prices trended upward each year.
“Prices, in particular, pose a challenge to affordable and accessible health care,” said Katie Martin, President and CEO of HCCI. “This report shows how spending has changed since 2018, and, despite some large impacts from the COVID-19 pandemic along the way, the net effect is that use, prices, and spending were all higher in 2022.”
Other key findings of the HCCUR include:
The HCCUR examines year-over-year and 5-year cumulative trends in health care spending for individuals with employer-sponsored insurance, segmented by health care service category. The findings in HCCUR are powered by HCCI data which holds claims data for more than 50 million commercially insured individuals. All data was weighted to reflect the age, gender and geographic mix of the employer-sponsored insurance population. The full report can be accessed here.
About Health Care Cost Institute
The Health Care Cost Institute is a mission-driven, non-profit at the nexus of data, analytics, and action. HCCI was founded in 2011 to leverage unique, high-quality data and extraordinary expertise in research and policy to give decisionmakers the tools they need to lower health care costs and increase value in the health care system. To learn more about HCCI, visit https://healthcostinstitute.org/.
CONTACT:
media@healthcostinstitute.org
(202) 803-5200
SOURCE Health Care Cost Institute
Hemogenyx Pharmaceuticals Receives IRB Approval for Phase 1 Clinical Trial of HEMO-CAR-T (HG-CT-1)LONDON, UK /…
SAN DIEGO, CA / ACCESSWIRE / November 21, 2024 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular…
BEVERLY HILLS, CALIFORNIA / ACCESSWIRE / November 21, 2024 / Nicole Garrett, CEO of Under…
HUNTINGTON BEACH, Calif., Nov. 21, 2024 /PRNewswire/ -- Beacon Healthcare Systems, is pleased to announce…
Attributes Revenue Growth to Innovative Partnerships, Strong Team, and Unique Value-Based Care Model NEW YORK,…
Automation That Makes a Difference SUNRISE, Fla., Nov. 21, 2024 /PRNewswire/ -- When it comes…